• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于抗癌药物控释的聚乳酸/壳聚糖杂化纳米粒子

Poly(lactic acid)/chitosan hybrid nanoparticles for controlled release of anticancer drug.

作者信息

Wang Wenlong, Chen Shu, Zhang Liang, Wu Xi, Wang Jiexin, Chen Jian-Feng, Le Yuan

机构信息

State Key Laboratory of Organic-Inorganic Composites, Beijing University of Chemical Technology, Beijing 100029, PR China.

Department of Chemical Engineering, University College of London, Gower Street, London, England.

出版信息

Mater Sci Eng C Mater Biol Appl. 2015 Jan;46:514-20. doi: 10.1016/j.msec.2014.10.048. Epub 2014 Oct 23.

DOI:10.1016/j.msec.2014.10.048
PMID:25492016
Abstract

Poly(lactic acid) (PLA) is a kind of non-toxic biological materials with excellent absorbability, biocompatibility and biodegradability, which can be used for drug release, tissue engineering and surgical treatment applications. In this study, we prepared chitosan modified PLA nanoparticles as carriers for encapsulation of docetaxel by anti-solvent precipitation method. The morphology, particle size, zeta potential and composition of the PLA/chitosan were characterized by SEM, DLS, FTIR and XPS. As-prepared PLA/chitosan particles exhibited average size of 250 nm and showed very narrow distribution with polydispersity index of 0.098. Their large surface charge-ability was confirmed by zeta potential value of 53.9 mV. Docetaxel was released from PLA/chitosan nanoparticles with 40% initial burst release in 5 h and 70% cumulative release within 24 h, while from PLA nanoparticles 65% of docetaxel was released in 5h. In vitro drug release study demonstrated that PLA/chitosan nanoparticles prolonged drug release and decreased the burst release over the unmodified PLA nanoparticles. These results illustrated high potential of chitosan modified PLA nanoparticles for usage as anticancer drug carriers.

摘要

聚乳酸(PLA)是一种无毒的生物材料,具有优异的吸收性、生物相容性和生物降解性,可用于药物释放、组织工程和外科治疗应用。在本研究中,我们通过反溶剂沉淀法制备了壳聚糖修饰的PLA纳米颗粒作为多西他赛的包封载体。通过扫描电子显微镜(SEM)、动态光散射(DLS)、傅里叶变换红外光谱(FTIR)和X射线光电子能谱(XPS)对PLA/壳聚糖的形态、粒径、zeta电位和组成进行了表征。所制备的PLA/壳聚糖颗粒的平均粒径为250nm,分散指数为0.098,显示出非常窄的粒径分布。zeta电位值为53.9mV证实了它们具有较大的表面带电能力。多西他赛从PLA/壳聚糖纳米颗粒中释放,在5小时内初始突释率为40%,24小时内累积释放率为70%,而从PLA纳米颗粒中5小时内多西他赛的释放率为65%。体外药物释放研究表明,与未修饰的PLA纳米颗粒相比,PLA/壳聚糖纳米颗粒延长了药物释放并降低了突释。这些结果表明壳聚糖修饰的PLA纳米颗粒作为抗癌药物载体具有很高的潜力。

相似文献

1
Poly(lactic acid)/chitosan hybrid nanoparticles for controlled release of anticancer drug.用于抗癌药物控释的聚乳酸/壳聚糖杂化纳米粒子
Mater Sci Eng C Mater Biol Appl. 2015 Jan;46:514-20. doi: 10.1016/j.msec.2014.10.048. Epub 2014 Oct 23.
2
Chitosan/PLA nanoparticles as a novel carrier for the delivery of anthraquinone: synthesis, characterization and in vitro cytotoxicity evaluation.壳聚糖/PLA 纳米粒作为蒽醌类药物的新型载体:合成、表征及体外细胞毒性评价。
Colloids Surf B Biointerfaces. 2013 Jan 1;101:126-34. doi: 10.1016/j.colsurfb.2012.06.019. Epub 2012 Jun 28.
3
Enhanced anti-topoisomerase II activity by mucoadhesive 4-CBS-chitosan/poly (lactic acid) nanoparticles.通过黏附性 4-CBS-壳聚糖/聚乳酸纳米粒增强抗拓扑异构酶 II 活性。
Carbohydr Polym. 2013 Nov 6;98(2):1335-42. doi: 10.1016/j.carbpol.2013.08.006. Epub 2013 Aug 7.
4
Formation and characterization of chitosan-polylacticacid-polyethylene glycol-gelatin nanoparticles: a novel biosystem for controlled drug delivery.壳聚糖-聚乳酸-聚乙二醇-明胶纳米粒的形成与表征:一种新型的控制药物释放的生物体系。
Carbohydr Polym. 2013 Oct 15;98(1):951-8. doi: 10.1016/j.carbpol.2013.05.025. Epub 2013 May 21.
5
Chitosan grafted low molecular weight polylactic acid for protein encapsulation and burst effect reduction.壳聚糖接枝低分子量聚乳酸用于蛋白质包封和降低突释效应。
Int J Pharm. 2015 Dec 30;496(2):912-21. doi: 10.1016/j.ijpharm.2015.10.017. Epub 2015 Oct 24.
6
[PLA-O-CMC nanoparticles: HGF loading and delivery behaviors in vitro].[聚乳酸-羟基乙酸共聚物-氧化羧甲基纤维素纳米颗粒:肝细胞生长因子的体外装载与递送行为]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2011 Apr;28(2):314-7.
7
Modified PLA nano in situ gel: a potential ophthalmic drug delivery system.改性 PLA 纳米原位凝胶:一种有潜力的眼科药物传递系统。
Colloids Surf B Biointerfaces. 2011 Aug 1;86(1):28-34. doi: 10.1016/j.colsurfb.2011.03.023. Epub 2011 Mar 23.
8
PLA/PLGA nanoparticles for sustained release of docetaxel.用于多西他赛持续释放的聚乳酸/聚乳酸-羟基乙酸共聚物纳米颗粒
Int J Pharm. 2006 Nov 15;325(1-2):172-9. doi: 10.1016/j.ijpharm.2006.06.023. Epub 2006 Jun 23.
9
Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats.经鼻腔给予清醒大鼠载神经毒素 PLA 纳米粒经壳聚糖修饰后的脑药代动力学。
Drug Dev Ind Pharm. 2013 Nov;39(11):1618-24. doi: 10.3109/03639045.2012.727828.
10
Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.用于多西他赛口服递送的聚丙交酯-维生素E衍生物/蒙脱石纳米颗粒制剂
Biomaterials. 2009 Jul;30(19):3297-306. doi: 10.1016/j.biomaterials.2009.02.045. Epub 2009 Mar 19.

引用本文的文献

1
GSH/pH-Responsive Chitosan-PLA Hybrid Nanosystems for Targeted Ledipasvir Delivery to HepG2 Cells: Controlled Release, Improved Selectivity, DNA Interaction, Electrochemical and Stopped-Flow Kinetics Analyses.用于将雷迪帕韦靶向递送至HepG2细胞的谷胱甘肽/ pH响应型壳聚糖-聚乳酸混合纳米系统:控释、选择性提高、DNA相互作用、电化学和停流动力学分析
Int J Mol Sci. 2025 Jun 24;26(13):6070. doi: 10.3390/ijms26136070.
2
The Chemical Modification to Improve Solubility of Chitosan and Its Derivatives Application, Preparation Method, Toxicity as a Nanoparticles.改善壳聚糖及其衍生物溶解度的化学修饰、应用、制备方法、作为纳米颗粒的毒性
Nanotechnol Sci Appl. 2024 Mar 7;17:41-57. doi: 10.2147/NSA.S450026. eCollection 2024.
3
Mesoporous Particle Embedded Nanofibrous Scaffolds Sustain Biological Factors for Tendon Tissue Engineering.
介孔粒子嵌入纳米纤维支架用于肌腱组织工程的生物因子缓释
ACS Mater Au. 2023 Jul 24;3(6):636-645. doi: 10.1021/acsmaterialsau.3c00012. eCollection 2023 Nov 8.
4
Advances in Designing Essential Oil Nanoformulations: An Integrative Approach to Mathematical Modeling with Potential Application in Food Preservation.精油纳米制剂设计进展:数学建模的综合方法及其在食品保鲜中的潜在应用
Foods. 2023 Nov 3;12(21):4017. doi: 10.3390/foods12214017.
5
Recent Overview of Resveratrol's Beneficial Effects and Its Nano-Delivery Systems.白藜芦醇的有益作用及其纳米递药系统的最新概述。
Molecules. 2022 Aug 12;27(16):5154. doi: 10.3390/molecules27165154.
6
Development of Biodegradable Polymer Blends Based on Chitosan and Polylactide and Study of Their Properties.基于壳聚糖和聚乳酸的可生物降解聚合物共混物的研制及其性能研究。
Materials (Basel). 2021 Aug 28;14(17):4900. doi: 10.3390/ma14174900.
7
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors.有效利用纳米载体作为治疗特定肿瘤的药物递送系统。
Int J Nanomedicine. 2017 Oct 5;12:7291-7309. doi: 10.2147/IJN.S146315. eCollection 2017.
8
Preparation and characterisation of atorvastatin and curcumin-loaded chitosan nanoformulations for oral delivery in atherosclerosis.用于动脉粥样硬化口服给药的阿托伐他汀和姜黄素负载壳聚糖纳米制剂的制备与表征
IET Nanobiotechnol. 2017 Feb;11(1):96-103. doi: 10.1049/iet-nbt.2016.0062.
9
Development of oral dispersible tablets containing prednisolone nanoparticles for the management of pediatric asthma.用于治疗小儿哮喘的含泼尼松龙纳米颗粒口腔崩解片的研发。
Drug Des Devel Ther. 2015 Nov 20;9:5815-25. doi: 10.2147/DDDT.S86075. eCollection 2015.